Na Linha com Mário Kertész · Mário Kertész

10-04-26 - ENTREVISTA CEUCI NUNES

·30 min·2 clips
Dr. Ceuci Nunes, who led Brazil's COVID fight, reveals how Bahia Pharma is now producing high-tech monoclonal antibodies.
1. Mário Kertész interviews Dr. Ceuci Nunes, infectologist and president of Bahia Farma, on the state pharmaceutical lab's current activities and her COVID-19 frontline experience. 2. Dr. Nunes is described as a medical scientist who led infectious disease treatment at Cotumaia Hospital in Salvador and now oversees Bahia Farma under the mandate of Governor Gerônimo and Secretary Roberta. 3. The episode's central thesis is that Brazil's public health infrastructure — Bahia Farma, SUS, and science-based protocols — proved decisive during COVID-19 and remains under political and market pressure. 4. Bahia Farma was dissolved in 1996 and revived in 2011; under the current Lula administration, it received approval for 4 technology-transfer projects under the Ministry of Health's PDP program. 5. The approved projects involve partnerships with Indian companies Dr. Reddy's and Biocon, Korean conglomerate Samsung, and Brazilian national firm Bionovis, all focused on biological medicines — specifically monoclonal antibodies for rare cancers. 6. Dr. Nunes notes that monoclonal antibodies are produced by only five countries globally: the United States, India, China, South Korea, and Brazil through its public laboratories. 7. On SUS, Dr. Nunes argues that Brazil's 700,000 COVID deaths would have been far higher without the system's national bed-opening capacity and capillary reach into municipalities. 8. She recounts that the Bolsonaro-era Ministry of Health called Cotumaia Hospital on the first day its COVID ward opened to ask whether patients were real or fabricated. 9. Dr. Nunes describes the Covida research group — including epidemiologist Professor Maurício Barreto — which held conferences with Italian and UK scientists to build hospital-level treatment protocols. 10. Those protocols gave Cotumaia doctors documented authority to decline patient requests for chloroquine and ivermectin, which she calls the key institutional defense against misinformation. 11. The Bolsonaro government suspended official COVID death counts, prompting a press consortium to compile and publish its own daily figures for the first time in Brazilian journalism. 12. Dr. Nunes draws a link between Robert F. Kennedy Jr.'s anti-vaccine positions in the US and the dismantling of the CDC, noting that many high-level CDC epidemiologists resigned rather than comply. 13. She attributes high rates of Bolsonaro support among physicians to the historically elite, conservative nature of medical school admissions in Brazil, combined with opposition to SUS as a 'communist' idea. 14. On the question of why a conservative, market-oriented syndicate cannot effectively represent doctors, Dr. Nunes argues that defending market competition is structurally incompatible with fighting for consultation time, salaries, and dignified working conditions. 15. Health plans in Brazil currently require consultations as short as eight minutes, and one plan referenced by the hosts allegedly restricts doctors to 45 diagnostic exams per authorization cycle. 16. An explosion of medical schools opened through judicial orders rather than Ministry of Education authorization, flooding the market with graduates and weakening collective bargaining leverage. 17. The tone is conversational and politically engaged — Kertész probes with short prompts and personal recollections, while Nunes responds with extended analytical answers rooted in clinical and institutional experience. 18. The discussion is emotionally direct, particularly when Nunes says the smell of hospitals now triggers distress from her COVID experience, and when both reflect on Manaus mass graves. 19. Brazilian public health professionals, progressively-aligned physicians, and voters interested in Brazil's healthcare system politics will find this most valuable. 20. Listeners uncomfortable with Brazilian partisan framing or those seeking clinical detail beyond COVID protocol overview may find the political commentary predominant.
Listen to the show on